These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
3. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses. Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P J Virol; 2017 May; 91(9):. PubMed ID: 28179535 [TBL] [Abstract][Full Text] [Related]
4. Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice. Lo CY; Misplon JA; Li X; Price GE; Ye Z; Epstein SL Vaccine; 2021 Jul; 39(33):4628-4640. PubMed ID: 34226103 [TBL] [Abstract][Full Text] [Related]
5. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains. Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789 [TBL] [Abstract][Full Text] [Related]
6. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines. Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H mBio; 2019 Sep; 10(5):. PubMed ID: 31530680 [TBL] [Abstract][Full Text] [Related]
7. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793 [TBL] [Abstract][Full Text] [Related]
8. An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus. Schwartzman LM; Cathcart AL; Pujanauski LM; Qi L; Kash JC; Taubenberger JK mBio; 2015 Jul; 6(4):e01044. PubMed ID: 26199334 [TBL] [Abstract][Full Text] [Related]
9. Towards a universal influenza vaccine: different approaches for one goal. Sautto GA; Kirchenbaum GA; Ross TM Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862 [TBL] [Abstract][Full Text] [Related]
11. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses. Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350 [TBL] [Abstract][Full Text] [Related]
12. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses. Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203 [TBL] [Abstract][Full Text] [Related]
13. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection. Jang YH; Seong BL Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765 [TBL] [Abstract][Full Text] [Related]
17. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model. Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL Front Immunol; 2018; 9():116. PubMed ID: 29449842 [TBL] [Abstract][Full Text] [Related]
18. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice. Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985 [TBL] [Abstract][Full Text] [Related]
19. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine. Fox A; Quinn KM; Subbarao K Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204 [TBL] [Abstract][Full Text] [Related]
20. Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. Rajão DS; Pérez DR Front Microbiol; 2018; 9():123. PubMed ID: 29467737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]